There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological...
"This is a dramatic change to the pipeline for Vernalis." There are 35m prescriptions for cough and cold remedies in the US every year and there is only one slow-release product on the market, UCB's Tussionex. Vernalis' fundraising at 20p a share,...
Susan Axelrod, president of CURE, a non-profit pursuing a cure for epilepsy, and wife of former White House advisor David Axelrod (in center), joined by Prof. Isaac Kohlberg, Chief Technology Officer, Harvard University (on left), and Prof. Ismail... View Photo »
So we [the board] unanimously decided to give him a pension and gift for a job well done. UCB gave him R5-million
Moreover, sales may be impacted by international and domestic trends toward managed care and health care cost containment and the reimbursement policies imposed by third-party payers as well as legislation affecting biopharmaceutical pricing and...
Employing more than 9000 people in over 40 countries, UCB produced revenue of EUR 3.22 billion in 2010. UCB is listed on Euronext Brussels (symbol: UCB). This press release contains forward-looking statements based on current plans, estimates and...
Today’s question we posed to the web: What Cardinal do you expect to be the biggest flop in 2012 for the Cardinals? Let’s go to the answers. Wow, that’s a tough one…I agree with Bill on Jay – the guy has yet to weather the doldrums of a full season as a...
BEVERLY HILLS, CA - MAY 12: Executive Council Chairman of Lupus LA Adam Selkowitz (L) with UCB Medical Visionary Honorees arrive at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California... View Photo »
At no stage since my retirement has the UCB or CSA made any contribution to my medical aid
UCB (United Cardinal Blogs) roundtable is back. Today's question we posed to the web: What Cardinal do you expect to be the biggest flop in 2012 for the Cardinals? Let's go to the answers. Cards N' Stuff: Wow, that's a tough one...I agree with Bill on...
“Earth is losing a huge amount of ice to the ocean annually, and these new results will help us answer important questions in terms of both sea rise and how the planet's cold regions are responding to global change,” UCB physics professor and study...
UCB (Euronext: UCB), is a global biopharmaceutical manufacturer headquartered in Brussels. It focuses on novel therapeutic solutions for patients with severe diseases treated by specialists, particularly in the fields of central nervous system disorders (including epilepsy), inflammatory disorders (including allergy) and oncology. Full Article
BEVERLY HILLS, CA - MAY 12: 2011 Orange Ball Honoree Dr. Iris Loew-Friedrich of UCB speaks onstage at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California.
View Photo »BEVERLY HILLS, CA - MAY 12: 2011 Orange Ball Honoree Dr. Iris Loew-Friedrich of UCB and singer Howie Dorough onstage at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California.
View Photo »The logo of Belgian drugmaker UCB is seen at the entrance of the company's headquarters in Brussels March 2, 2011. The company warned on Wednesday that generic competition to its top epilepsy medicine would cause sales and profits to decline this year, after 2010 beat expectations due...
View Photo »Chief Financial Officer of Belgian drugmaker UCB, Detlef Thielgen, presents the company's 2010 results in Brussels March 2, 2011. UCB warned generic competition to its top epilepsy medicine would cause sales and profits to decline this year, after 2010 beat expectations due to strong...
View Photo »Executive Vice President of Belgian drugmaker UCB, Ismail Kola (L) and UCB 's Chief Executive Officer Roch Doliveux, present the company's 2010 results in Brussels March 2, 2011. UCB warned generic competition to its top epilepsy medicine would cause sales and profits to decline this...
View Photo »Susan Axelrod, president of CURE, a non-profit pursuing a cure for epilepsy, and wife of former White House advisor David Axelrod (in center), joined by Prof. Isaac Kohlberg, Chief Technology Officer, Harvard University (on left), and Prof. Ismail Kola, President, UCB NewMedicines (on...
View Photo »BEVERLY HILLS, CA - MAY 12: Executive Council Chairman of Lupus LA Adam Selkowitz (L) with UCB Medical Visionary Honorees arrive at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California.
View Photo »A pharmacist holds up a box of Distilbene (diéthylstilboestrol or DES), on September 24, 2009 in Paris. Women suffering from cancer after being exposed in utero to the drug will no longer have to prove which brand of the drug their mother took during pregnancy, a court ruled today. ...
View Photo »BEVERLY HILLS, CA - MAY 12: 2011 Orange Ball Honoree Dr. Iris Loew-Friedrich of UCB speaks onstage at the 11th Annual Lupus LA Orange Ball held at the Beverly Wilshire Four Seasons Hotel on May 12, 2011 in Beverly Hills, California.
View Photo »So we [the board] unanimously decided to give him a pension and gift for a job well done. UCB gave him R5-million
At no stage since my retirement has the UCB or CSA made any contribution to my medical aid
UCB is committed to making a difference in the lives of people affected by Crohn's disease ... At UCB, we consider it a privilege to provide assistance to individuals using education to live more fully outside the limitations of Crohn's disease.
UCB is committed to making a difference in the lives of people affected by Crohn's disease ... At UCB, we consider it a privilege to provide assistance to individuals using education to live more fully outside the limitations of Crohn's disease.
At UCB, we are committed to working toward improving the lives of people living with epilepsy
UCB New Medicines™ is deploying a wide range of innovative and proprietary science and technologies in its search for breakthrough medicines. Lectus’s drug discovery and development programmes supports our research efforts in the CNS field. I feel confident it will enable us to further honour our commit...
I did some stuff in high school and then I saw a really cool show that was like a UCB showcase ... I asked them how to get involved and they told me to go take classes. So pretty much, you go to the UCB in New York and start taking classes and you’re in.
I did some stuff in high school and then I saw a really cool show that was like a UCB showcase ... I asked them how to get involved and they told me to go take classes. So pretty much, you go to the UCB in New York and start taking classes and you’re in.
A full-suite adoption to ContractSphere produces significant efficiency gains for UCB by eliminating disparate systems, streamlining the management of the entire contract lifecycle, and leveraging industry best practices and delivering an immediate Return on Investment (ROI)
We believe the terms of this agreement are very favourable to UCB, especially in the light of its smaller size. Through the agreement, UCB is looking to expedite drug development and drive cost savings.
We believe the terms of this agreement are very favourable to UCB, especially in the light of its smaller size. Through the agreement, UCB is looking to expedite drug development and drive cost savings.
Through the strategic partnership, PAREXEL will assist UCB to improve efficiency and cost effectiveness, and support increased opportunity for innovation, collaboration and the continuous improvement of quality and services -- helping us to deliver new medicines to patients worldwide
